Gendell Jeffrey L’s Avadel Pharmaceuticals AVDL Stock Holding History

Gendell Jeffrey L’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,131,500	Closed	-$24.4M	–	102
2025 Q4	$24.4M	Buy	+1,131,500	New	+$22M	0.42%	27

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Gendell Jeffrey L's AVDL Position: Q1 2026 in Review

Gendell Jeffrey L sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 4,769,357 shares — an estimated $103M sold.

Gendell Jeffrey L first reported a position in AVDL in Q3 2019 and held it in 26 quarters. The position peaked at $103M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Gendell Jeffrey L reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Gendell Jeffrey L sold 4,769,357 Avadel Pharmaceuticals shares in Q1 2026, an estimated $103M.
Gendell Jeffrey L first reported a position in Avadel Pharmaceuticals in Q3 2019 and held it in 26 quarters.
Gendell Jeffrey L's Avadel Pharmaceuticals position peaked at $103M in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Gendell Jeffrey L's 13F filing for Q1 2026, filed 15 May 2026.